MeTA is applying a range of tools to support the process of collecting and disclosing data about medicines
Collecting data about access to medicines and multi-stakeholder processes is a critical component of MeTA
A crucial first step to determine barriers and best approaches to better medicines promotion
MeTA Executive Director sets out reasons for pharmaceutical industry involvement.
HAI technical briefing on initiatives that address the consequences of unethical pharmaceutical promotion.
MeTA IAG member sees transparency as key in the ethical promotion of medicines.